Zhe Wang

Zhe Wang

Auto-generated profile, based on publicly available information

Zhe Wang

Acupuncture and Tuina College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2026 in Acupuncture in Medicine
Verified
Journal Article
Closed access
HZHao Zheng
Hao Zheng
ZWZhe Wang
Zhe Wang
SWShi-Jie Wei
Shi-Jie Wei
LHLi-Xia Huang
Li-Xia Huang
MHMeng Han
Meng Han
JHJing Han
Jing Han
Objective: The aim of this study was to investigate the effects of acupuncture on a rat model of chronic migraine (CM) and explore the underlying mechanism of action from the perspective of the gut–brain axis. Methods: A total of 24 male Sprague-Dawley (SD) rats were randomly allocated into control, model and acupuncture groups ( n = 8 each). The CM model was established by intraperitoneal injection of nitroglycerin (NTG). Acupuncture was administered at GV20 and bilateral PC6/LR3/ST36 for rats in the acupuncture group once a day for 9 days. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of 5-hydroxytryptamine (5-HT), calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP) in plasma. A combination of 16S rDNA sequencing and liquid chromatography-mass spectrometry (LC-MS) metabolomics was adopted to investigate the role of the gut–brain axis in migraine chronification and the effect of acupuncture on CM. Results: Acupuncture treatment significantly attenuated hyperalgesia in CM model rats and regulated serum levels of brain–gut peptides, including 5-HT, CGRP and VIP. Furthermore, the gut microbial community structure and metabolic profile changed in CM rats and acupuncture impacted the changes. Notably, acupuncture modulated 10 gut microbial genera and 13 fecal metabolites. Conclusion: These findings suggest that the gut–brain axis may play an important role in the chronification of migraine, and the regulation of gut microbiota and metabolites may be one of the mechanisms underlying the analgesic effect of acupuncture in CM.

7 May 2026 in Integrative Medicine Research
Verified
Journal Article
Open access
YYYuanyuan Yao
Yuanyuan Yao
HLHui Liu
Hui Liu
DYDaoze Yang
Daoze Yang
XLXufei Luo
Xufei Luo
HLHonghao Lai
Honghao Lai
ZBZhaoxiang Bian
Zhaoxiang Bian
Large language models (LLMs) have attracted increasing attention in medical research and clinical practice and have been applied to processes related to evidence-based medicine (EBM). However, the extent of their integration with evidence-based Chinese medicine (CM) remains unclear. We systematically searched PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang Data from 30 November 2022 to 31 January 2026, with supplementary searches conducted in Google Scholar. Studies were included if they applied LLMs to EBM processes within a CM context or investigated LLMs in CM using established evidence-based research designs. Descriptive analysis summarized study characteristics, and findings were mapped according to the evidence ecosystem framework. A total of 12 studies published between 2023 and 2025 were included. Most studies integrated LLMs into different stages of the EBM workflow within a CM context. At the evidence generation stage, studies explored the role of LLMs in identifying research priorities. At the evidence synthesis stage, LLM performance was evaluated in literature screening, data extraction, and risk-of-bias assessment. At the evidence translation stage, studies evaluated the performance of LLMs in guideline-related question answering and recommendation generation. At the evidence implementation stage, LLMs combined with knowledge graphs or retrieval-augmented generation were used to develop intelligent question-answering systems based on CM guidelines or standards. Existing studies suggest that LLMs have begun to be explored across multiple stages of evidence-based CM research and show potential for improving evidence synthesis efficiency and supporting knowledge translation and application. Open Science Framework (https://osf.io/ztbd5/overview).

1 January 2026 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
ZWZhe Wang
Zhe Wang
YLYuhao Li
Yuhao Li
SFShuo Feng
Shuo Feng
XZXinjing Zhao
Xinjing Zhao
XYXinyue Yang
Xinyue Yang
JHJing Han
Jing Han
Migraine affects over one billion people worldwide and imposes substantial burdens, yet the lifetime risk of developing migraine has been understudied. Using Global Burden of Disease 2021 data, we estimated age‐, sex‐, and location‐specific lifetime probabilities with the adjusted‐for‐multiple‐primaries method, which accounts for competing mortality and life expectancy. Trends were quantified by average annual percentage change, socioeconomic inequality by concentration indices, and future trajectories with autoregressive integrated moving average models. In 2021, the global lifetime probability of migraine was 51.53% (95% CI: 51.51%–51.55%); females faced a higher risk than males (59.84% vs. 41.99%; ratio: 1.42). Regional estimates ranged from 60.58% in Western Europe to 35.63% in Eastern Sub‐Saharan Africa, paralleling the sociodemographic index gradient (high SDI 55.74% vs. low SDI 45.13%). Risk accumulated mainly during early and middle adulthood. The concentration index declined from 0.35 in 1990 to 0.27 in 2021, indicating reduced socioeconomic disparities, while projections suggest global lifetime risk will rise to 57.18% by 2050. Roughly half the world’s population is therefore expected to experience migraine during their lives, with pronounced heterogeneity by sex, region, and socioeconomic level, underscoring the need for targeted public‐health strategies, particularly for younger individuals during high‐riskperiods.

1 September 2026 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
ZWZhe Wang
Zhe Wang
LTLin Tian
Lin Tian
GWGuiying Wang
Guiying Wang
XMXianqing Meng
Xianqing Meng
TBTianyu Bai
Tianyu Bai
JHJing Han
Jing Han
Background: Needlestick injuries (NSIs) are a major occupational hazard for healthcare workers, but evidence on acupuncture-related NSIs remains limited. Methods: A multicenter cross-sectional survey was conducted among acupuncture physicians, students, and nurses across 10 provinces in China from February to July 2025. Past-year and lifetime NSI prevalence, severe NSI prevalence, and blood-exposure NSI prevalence were estimated. Incidence density was calculated as the number of injuries per 1000 person-years. Multivariable logistic regression was used to identify factors associated with past-year NSI occurrence and non-reporting. Results: A total of 2147 participants were included. Past-year and lifetime NSI prevalence were 40.71% and 55.43%. Physicians had the highest past-year prevalence (49.22%), followed by students (43.19%) and nurses (17.42%). The overall incidence density was 998.14 per 1000 person-years. Acupuncture needles were the most frequently implicated device (85.38%), and needle removal was the most common injury scenario (71.34%). Only 24.12% of participants always reported NSIs, while 34.96% never reported any NSI. Training was associated with reduced NSI risk and reduced non-reporting behavior. Hepatitis B vaccination coverage remained suboptimal, particularly among students. Conclusion: Acupuncture-related NSIs are frequent and substantially underreported in China. Occupation-specific training, strengthened controls for high-risk workflows, higher vaccination coverage, and improved reporting systems are needed.

27 November 2024 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
WWWang Wen
Wang Wen
WZWang Zhe
Wang Zhe
CQChen Qianxiu
Chen Qianxiu
SHSun Haixia
Sun Haixia
FZFu Zongchao
Fu Zongchao
LHLv Hao
Lv Hao
Asfotase alfa (AA) is an FDA-approved enzyme replacement therapy for hypophosphatasia (HPP). Limited real-world data on its adverse events (AEs) exist. This study evaluates AA-related AEs using the U.S. FDA's Adverse Event Reporting System (FAERS) database. Reports for AA were extracted from FAERS and analyzed per FDA guidelines. AEs were categorized using MedDRA version 26.1. Disproportionality analysis was conducted using the reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayes geometric mean (EBGM) algorithms. Time-to-onset (TTO) was calculated, with a Weibull shape parameter test to assess risk over time. Out of 13,702,373 reports, 5,040 AA-related AEs were identified, with 198 significant preferred terms (PTs). Common AEs included injection site reactions and pain, with additional PTs for ear/labyrinth disorders and infections. The median onset for 234 AEs with reported times was 170 days (IQR 18-390 days). No significant differences in AEs were found across gender or age groups. Most AEs align with known data, but newly identified ear/labyrinth disorders and infections require further investigation to enhance AA's safety profile.